In conclusion, our results demonstrated that high expression of AnxA2 promotes proliferation, migration, and invasion in bladder cancer cells, and AnxA2 mRNA expression was significantly associated with the poor prognosis of BLCA patients. The gene discussed is ANXA2; the disease is urinary bladder carcinoma.